Candel Shares Rise Following Positive Prostate Cancer Trial Results
Daily NewsOn Wednesday, Candel Therapeutics, Inc. (NASDAQ:CADL) shares saw a significant increase of 150% following the release of positive results from the company's Phase...
Read More